SLC39A7

Zinc transporter SLC39A7 · Q92504 · SLC39A7 on Sugi Atlas →

11 patent compounds predicted against SLC39A7, 8 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours
SCHEMBL30562782 SCHEMBL30562782 1.00 1/20
SCHEMBL13052383 SCHEMBL13052383 0.48 1/20
SCHEMBL18491021 SCHEMBL18491021 0.44 1/20
SCHEMBL13314938 SCHEMBL13314938 0.42 1/20
SCHEMBL27048955 SCHEMBL27048955 0.42 1/20
SCHEMBL13314935 SCHEMBL13314935 0.40 1/20
SCHEMBL13314944 SCHEMBL13314944 0.40 1/20
SCHEMBL30800280 SCHEMBL30800280 0.40 1/20

Clinical trials — most relevant to SLC39A7 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Delivery of Iron and Zinc Supplements: Evaluation of Interaction Effect on Biochemical and Clinical Outcomes PHASE4COMPLETED
Bovine Lactoferrin to Prevent and Cure Iron Deficiency and Iron Deficiency Anemia in Complicated Pregnancies PHASE4COMPLETED
Zinc Supplementation in Patients With β-Thalassemia Major Complicated With Diabetes Mellitus PHASE3COMPLETED
Randomized Placebo-Controlled Trial (RPCT) of Maize/Zinc in Guatemala PHASE3COMPLETED
Oral N-acetylglucosamine in Crohn's Disease PHASE2NOT_YET_RECRUITING
Safety and Dose Escalation Study of Zinc Supplementation in Critically Ill Children PHASE1/PHASE2COMPLETED
Role of Metal Ion Transporter ZIP8 in Alcohol-Related Behaviors PHASE1RECRUITING
Randomized Clinical Trial: IS Zinc and Zinc Ionophere EGCG as Supplement Improve Outcome of Active Pulmonary Tuberculosis PHASE1UNKNOWN
The Study of Quadruple Therapy Quercetin, Zinc, Metformin, and EGCG as Adjuvant Therapy for Early, Metastatic Breast Cancer and Triple-negative Breast Cancer, a Novel Mechanism EARLY_PHASE1UNKNOWN
Allogeneic Anti-CD7 CAR-T for Type 1 Diabetes EARLY_PHASE1RECRUITING
Determination of Pre-Absorptive Dissociation of Zinc From a Zinc Amino Acid Complex in Healthy Men nanCOMPLETED
Zn Supplementation in HIV Immunological Non Responders nanRECRUITING
Nutrigenomics of Zinc Supplementation in Insulin Secretion and Diabetes nanCOMPLETED
Zinc and Diabetes in Patients With Thalassemia: a Pilot Study nanCOMPLETED
Exchangeable Zinc Pool Size and Zn Absorption From Sprinkles and Traditional Foods in Pakistani Infants /Toddlers nanCOMPLETED
Serum Zinc and Serum Magnesium in Chronic Liver Disease Patients nanCOMPLETED
Zinc Sulfate Acceptability nanCOMPLETED
Zinc and the Synthesis of Zinc Binding Proteins (Protocol B) nanCOMPLETED
Role of the ATP7A Transporter in Ovarian Cancer nanCOMPLETED
Copper Supplementation in Cirrhosis nanRECRUITING
Oral Zinc for the Treatment of Acute Diarrhea in US Children nanCOMPLETED
Genetic Study of Severe Zinc Deficiencies nanCOMPLETED
Effects of EED on Zn Absorption and Retention in Children From a MNP nanCOMPLETED
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF) nanCOMPLETED
Role of USP35 in the Detection of Ferroptosis in Juvenile Autoimmune Hepatitis nanNOT_YET_RECRUITING
Efficacy of Zinc Fortified Fermented Wheat Flour nanCOMPLETED
The Efficacy of Zinc-biofortified Rice in Bangladeshi Children nanCOMPLETED
Establishment of Human Cellular Disease Models for Wilson Disease nanCOMPLETED
Incidence of Iron Deficiency in Polycythemia Vera (PV) and Association With Disease Features nanUNKNOWN
Impact of Consumption of Orange-fleshed Sweet Potatoes on the Vitamin A Status of Bangladeshi Women of Reproductive Age nanCOMPLETED

Related proteins — ESM-2 sequence neighbours (a SLC39A7 binder may also engage these)

ProteinNameSimilarity
Q6MGB4 1.000 Q6MGB4 →
Q5RFD5 1.000 Q5RFD5 →
Q5TJF6 1.000 Q5TJF6 →
Q31125 0.996 Q31125 →
Q29175 0.985 Q29175 →
Q60738 0.964 Q60738 →
Q9PUB8 0.964 Q9PUB8 →
Q4R6K2 0.964 Q4R6K2 →
Q6P5W5 0.961 Q6P5W5 →
A0JPN2 0.957 A0JPN2 →
Q78IQ7 0.956 Q78IQ7 →
Q9V3A4 0.956 Q9V3A4 →
Q3UVU3 0.955 Q3UVU3 →
Q62720 0.954 Q62720 →
L5KLU7 0.954 L5KLU7 →
Q1KZG0 0.953 Q1KZG0 →
Q9D856 0.953 Q9D856 →
Q9M647 0.953 Q9M647 →
Q6L8F3 0.952 Q6L8F3 →
Q8BLV3 0.952 Q8BLV3 →
Q8VBT0 0.952 Q8VBT0 →
Q8IUH8 0.951 Q8IUH8 →
P0DX17 0.951 P0DX17 →
TMX1 Thioredoxin-related transmembrane protein 1 0.950 landscape →
Q13433 0.950 Q13433 →
Q5R9M9 0.950 Q5R9M9 →
Q9VAF0 0.949 Q9VAF0 →
Q9HCE9 0.949 Q9HCE9 →
Q9Y6M5 0.949 Q9Y6M5 →
SLC34A1 Sodium-dependent phosphate transport protein 2A 0.949 landscape →